Sangbit Paul

Sangbit Paul is an Executive at Biocon since May 2022, with prior experience as a Drug Safety Associate at WIPRO from May 2021 to November 2021, where responsibilities included case processing for US and Italy Covid-19 Pfizer vaccine cases. Sangbit Paul holds a Master’s degree in Pharmacy with a specialization in Pharmaceutics and Drug Design from GITAM Deemed University (2019-2021) and a Bachelor’s degree in Pharmacy from Siksha 'O' Anusandhan University (2015-2019). Educational background includes attending St. Stephen's School in DumDum.